AG˹ٷ

STOCK TITAN

Kimberly-Clark Announces Second Quarter 2025 Results, Raises 2025 Outlook

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Kimberly-Clark (Nasdaq: KMB) reported strong Q2 2025 results with net sales of $4.2 billion, showing organic sales growth of 3.9% despite a 1.6% overall decline. The company achieved its highest volume growth in five years at 5.0%, though this was partially offset by pricing investments of 1.2%.

Q2 adjusted EPS was $1.92, down 2.0% year-over-year, while adjusted gross margin decreased 180 basis points to 36.9%. The company raised its 2025 outlook, expecting low-to-mid single digit growth in adjusted operating profit and EPS on a constant-currency basis, with adjusted free cash flow projected at approximately $2 billion.

Kimberly-Clark (Nasdaq: KMB) ha riportato risultati solidi nel secondo trimestre 2025 con vendite nette pari a 4,2 miliardi di dollari, mostrando una crescita organica delle vendite del 3,9% nonostante un calo complessivo dell'1,6%. L'azienda ha raggiunto la crescita del volume più alta degli ultimi cinque anni al 5,0%, anche se parzialmente compensata da investimenti sui prezzi dell'1,2%.

L'EPS rettificato del secondo trimestre è stato di 1,92 dollari, in calo del 2,0% su base annua, mentre il margine lordo rettificato è diminuito di 180 punti base attestandosi al 36,9%. L'azienda ha rivisto al rialzo le previsioni per il 2025, prevedendo una crescita a una cifra bassa o media del profitto operativo rettificato e dell'EPS a valuta costante, con un flusso di cassa libero rettificato stimato intorno a 2 miliardi di dollari.

Kimberly-Clark (Nasdaq: KMB) reportó sólidos resultados en el segundo trimestre de 2025 con ventas netas de 4.200 millones de dólares, mostrando un crecimiento orgánico de ventas del 3,9% a pesar de una caída general del 1,6%. La compañía alcanzó su mayor crecimiento en volumen en cinco años, con un 5,0%, aunque esto fue parcialmente compensado por inversiones en precios del 1,2%.

El BPA ajustado del segundo trimestre fue de 1,92 dólares, una disminución del 2,0% interanual, mientras que el margen bruto ajustado bajó 180 puntos básicos hasta el 36,9%. La empresa elevó su perspectiva para 2025, esperando un crecimiento de un solo dígito bajo a medio en el beneficio operativo ajustado y el BPA en moneda constante, con un flujo de caja libre ajustado proyectado en aproximadamente 2.000 millones de dólares.

Kimberly-Clark (나스�: KMB)� 2025� 2분기� 42� 달러� 순매�� 기록하며 견고� 실적� 발표했습니다. � 매출은 1.6% 감소했지�, 유기� 매출 성장률은 3.9%� 달성했습니다. 회사� 5� 만에 최고� 5.0%� 물량 성장� 기록했으�, 1.2%� 가� 투자� 일부 상쇄되었습니�.

2분기 조정 주당순이�(EPS)은 1.92달러� 전년 대� 2.0% 감소했으�, 조정� 총이익률은 180베이시스 포인� 하락� 36.9%� 기록했습니다. 회사� 2025� 전망� 상향 조정하며, 환율 변동을 제외� 기준으로 조정 영업이익� EPS가 저에서 중간 단일 자리 � 성장� 보일 것으� 예상하고, 조정� 잉여 현금흐름은 � 20� 달러� 전망했습니다.

Kimberly-Clark (Nasdaq : KMB) a annoncé de solides résultats pour le deuxième trimestre 2025 avec un chiffre d'affaires net de 4,2 milliards de dollars, affichant une croissance organique des ventes de 3,9% malgré une baisse globale de 1,6%. L'entreprise a enregistré la plus forte croissance en volume depuis cinq ans, à 5,0%, bien que cela ait été partiellement compensé par des investissements tarifaires de 1,2%.

Le BPA ajusté du deuxième trimestre s'est élevé à 1,92 dollar, en baisse de 2,0% par rapport à l'année précédente, tandis que la marge brute ajustée a diminué de 180 points de base pour atteindre 36,9%. La société a relevé ses prévisions pour 2025, s'attendant à une croissance à un chiffre faible à moyen du bénéfice d'exploitation ajusté et du BPA à taux de change constants, avec un flux de trésorerie disponible ajusté prévu à environ 2 milliards de dollars.

Kimberly-Clark (Nasdaq: KMB) meldete starke Ergebnisse für das zweite Quartal 2025 mit Nettoverkäufen von 4,2 Milliarden US-Dollar und einem organischen Umsatzwachstum von 3,9%, trotz eines Gesamtumsatzrückgangs von 1,6%. Das Unternehmen erzielte das höchste Volumenwachstum seit fünf Jahren von 5,0%, das jedoch teilweise durch Preisinvestitionen von 1,2% ausgeglichen wurde.

Das bereinigte Ergebnis je Aktie (EPS) für das zweite Quartal lag bei 1,92 US-Dollar, was einem Rückgang von 2,0% im Jahresvergleich entspricht, während die bereinigte Bruttomarge um 180 Basispunkte auf 36,9% sank. Das Unternehmen hob seine Prognose für 2025 an und erwartet ein wachstum im niedrigen bis mittleren einstelligen Bereich beim bereinigten operativen Gewinn und EPS auf konstantem Währungsniveau, mit einem bereinigten freien Cashflow von etwa 2 Milliarden US-Dollar.

Positive
  • Highest volume growth in 5 years at 5.0%
  • Strong organic sales growth of 3.9% in Q2
  • North America organic sales increased 4.3% with strong volume growth
  • Personal Care categories grew weighted share by 60 basis points
  • Adjusted free cash flow expected at approximately $2 billion for 2025
Negative
  • Overall net sales declined 1.6% to $4.2 billion
  • Adjusted EPS decreased 2.0% to $1.92
  • Adjusted gross margin fell 180 basis points to 36.9%
  • Operating profit declined 2.2% to $713 million
  • Year-to-date cash from operations decreased to $1.1 billion from $1.5 billion

Insights

KMB delivered strong Q2 volume growth despite price investments, raised 2025 outlook amid transformation strategy execution.

Kimberly-Clark's Q2 results demonstrate solid execution of their Powering Care transformation strategy, with organic sales growth of 3.9% primarily driven by impressive volume growth of 5.0% � their highest in five years. This volume performance is particularly noteworthy as it occurred despite deliberate price investments of -1.2% to strengthen competitive positioning.

The company reported Q2 net sales of $4.2 billion, down 1.6% year-over-year, but this decline was primarily due to strategic portfolio changes � the divestiture of their Personal Protective Equipment business and exit from private label diapers in the US � which reduced reported sales by approximately 4.4%. Currency headwinds further reduced sales by 1.0%.

Profitability metrics reveal both strategic investments and cost pressures. Adjusted gross margin of 36.9% declined 180 basis points year-over-year, reflecting planned price investments and tariff-related costs, partially offset by productivity gains. Adjusted EPS of $1.92 decreased 2.0% versus prior year, driven by these gross margin pressures.

By segment, North America organic sales grew 4.3% with 5.2% volume growth, while International Personal Care organic sales increased 3.3% with 4.8% volume growth. However, operating profit declined in both segments (-4.0% in NA, -12.9% in IPC) as price investments outpaced productivity gains.

Cash flow from operations fell to $1.1 billion from $1.5 billion last year, primarily due to lower operating profit. The company's balance sheet remains solid with total debt at $7.2 billion, down from $7.4 billion at year-end 2024.

Most significantly, management raised their 2025 outlook, now expecting low-to-mid single-digit growth in adjusted operating profit and EPS on a constant-currency basis. This upgraded outlook suggests confidence in their strategy of investing in innovation and improving price-value propositions to drive sustainable volume growth. The company's focus on brand-building and market share gains in key categories positions them well for continued momentum despite ongoing inflationary and competitive pressures.

Strong results driven by innovation-led volume growth, excellent commercial execution, and effective cost management in dynamic operating environment

Full year outlook reflects solid performance in second year of Powering Care transformation

DALLAS, Aug. 1, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (Nasdaq: KMB) today reported second quarter 2025 results driven by resilient consumer demand, the introduction of pioneering innovative new products, and leveraging sustained productivity momentum.

"Our second quarter results are indicative of the exceptional progress we are making executing our Powering Care strategy" said Kimberly-Clark Chairman and CEO, Mike Hsu. "This was a very active quarter and one of the strongest in our recent history. We delivered strong organic sales growth, fueled by the highest volume growth we've achieved in five years. Our durable brands, differentiated value propositions and innovation investments enabled us to enhance and maintain leading market share positions across categories and price tiers. We took decisive actions to set Kimberly-Clark up for enhanced, sustainable growth and profitability.

Hsu continued: "Our strategy comes to life through our people—I'm proud of how our team continues to perform as we transform. Despite a dynamic operating environment, we are well-positioned to deliver a strong second year of our transformation."

Quarter Highlights

  • Unless otherwise noted, reported results in this release are based on continuing operations and exclude the International Family Care and Professional ("IFP") business, which is reported as discontinued operations.
  • Net sales of $4.2 billion were down 1.6 percent, driven primarily by divestitures and business exits and unfavorable currency translation, with organic sales growth of 3.9 percent versus the prior year.
  • Reported gross margin was 35.0 percent; adjusted gross margin was 36.9 percent, down 180 basis points versus the prior year.
  • Diluted earnings per share ("EPS") attributable to Kimberly-Clark were $1.53; adjusted EPS attributable to Kimberly-Clark were $1.92, down 2.0 percent versus prior year.

Second Quarter 2025 Results

Net sales of $4.2 billion were1.6 percent lower than the prior year due to negative impacts of approximately 4.4 percent from a combination of the Personal Protective Equipment ("PPE") divestiture and the exit of the company's private label diaper business in the US and approximately 1.0 percentfrom foreign currency translation. Organic sales increased 3.9 percent driven by 5.0 percentvolume led growth partially offset by investments in price of 1.2 percent,while portfolio mix was broadly in line with a year ago.

Gross margin was 35.0 percent in the quarter, inclusive of $82 million, or approximately 190 basis points, of charges related to the 2024 Transformation Initiative. Excluding these charges, adjusted gross margin was 36.9 percent, down 180 basis points versus the prior year driven by unfavorable pricing net of cost inflation, reflecting planned investments to improve price:value tiers across the portfolio as well as incremental tariff-driven costs, that were partially offset by strong productivity gains.

Secondquarter operating profit was $592Dz compared to $539 million in the prior year. Operating profit in each period was inclusive of 2024 Transformation Initiative charges totaling $121 million and $190 million, respectively. Excluding these items, adjusted operating profit was $713 million, down 2.2percent versus the prior year driven by gross profit headwinds partially offset by planned lower marketing, research and general expenses.

Net interest expense was $62 million and in line with the prior year.

The second quarter effective tax rate was 22.6 percent, compared to 13.0 percent in the prior year. On an adjusted basis, the effective rate was 20.9 percent compared to 20.4 percent in the prior year.

Net income of equity companies was $47Dz compared to $63 million in the prior year driven primarily by unfavorable currency impacts.

Income from discontinued operations, net of income taxes was $68 million compared to $89 million in the prior year driven primarily by pre-tax separation costs of $33 million, partially offset by a reduction in depreciation and amortization expense of $10 million due to discontinued operations reporting requirements.

Diluted EPS attributable to Kimberly-Clark in the quarter were $1.53 on a reported basis, down from $1.61 in the prior year. These reported amounts are inclusive of charges related to the company's 2024 Transformation Initiative of $0.27 and $0.35, respectively, and $0.12 of IFP related separation charges in the quarter. On an adjusted basis, diluted EPS attributable to Kimberly-Clark decreased 2.0percent to $1.92 driven by lower adjusted operating profit and lower net income of equity companies.

Year-To-Date Results

For the first half of the year, sales of $8.2billion decreased 4.0 percentprimarily due to an approximately 3.4 percentnegative impact from a combination of the PPE divestiture and the exit of the company's private label diaper business in the US, as well as an approximately 1.7 percentnegative impact from foreign currency translation. Organic sales grew 1.2 percentprimarily from a 2.3 percentincrease in volume, partially offset by price investments of 1.2 percent, while portfolio mix was broadly in line with a year ago.

For the first half of the year, gross margin was 36.1percent, inclusive of $135Dz, or approximately 160 basis points, of charges related to the 2024 Transformation Initiative. Excluding these charges, adjusted gross margin was 37.7 percent, down 120basis points versus the prior year driven by unfavorable pricing net of cost inflation, reflecting planned investments to improve price:value tiers across the portfolio as well as incremental tariff-related costs, partially offset by strong productivity gains.

Year-to-date operating profit was $1.2billion, including $196Dz of costs related to the company's transformation initiative. Year-to-date adjusted operating profit was $1.4billion in 2025 versus $1.5billion in 2024, a decline of 4.7percent. This decline included an unfavorable impact from currency translation of 120 basis points and thegross profit headwinds discussed above, partially offset by planned lower marketing, research and general expenses.

Year-to-date effective tax rate was 23.1 percent, compared to 18.8 percent in the prior year. On an adjusted basis, the effective rate was 20.8 percentcompared to 21.8 percentin the prior year. The first half of 2025 benefited from the resolution of certain tax matters.

Net income of equity companies was $91Dz compared to $124Dz in the prior year driven primarily by unfavorable currency impacts.

Income from discontinued operations, net of income taxes was $171 million compared to $191 million in the prior year driven primarily by pre-tax separation costs of $33 million, partially offset by a reduction in depreciation and amortization expense of $10 million due to discontinued operations reporting requirements.

Through the first half of the year, diluted EPS attributable to Kimberly-Clark were $3.23on a reported basis, compared to $3.52last year. Excluding the impacts of the 2024 Transformation Initiative and IFP related separation charges, year-to-date adjusted EPS attributable to Kimberly-Clark were $3.85compared to $3.97 last year down 3.0percent including a currency translation headwind of 280 basis points.

Business Segment Results
(Unaudited)

Q2 change vs year ago (%)


Volume


Mix/Other


Net Price


Divestitures
and
Business
Exits(c)


Currency
Translation


Total(a)


Organic(b)

Consolidated


5.0


(0.1)


(1.2)


(4.4)


(1.0)


(1.6)


3.9

NA


5.2


(0.7)


(0.4)


(5.7)


(0.2)


(1.9)


4.3

IPC


4.8


1.2


(2.7)


(0.3)


(2.6)


0.4


3.3

YTD change vs year ago (%)


Volume


Mix/Other


Net Price


Divestitures
and
Business
Exits(c)


Currency
Translation


Total(a)


Organic(b)

Consolidated


2.3



(1.2)


(3.4)


(1.7)


(4.0)


1.2

NA


2.6


(0.3)


(0.5)


(4.3)


(0.3)


(2.9)


1.8

IPC


2.0


0.7


(2.6)


(0.3)


(4.3)


(4.5)


0.1

(a)

Total may not sum across due to rounding.

(b)

Represents the change in net sales excluding the impacts of currency translation and divestitures and business exits.
Organic Sales Growth is a non-GAAP financial measure. See "Summary of Non-GAAP Financial Measures" below for
reconciliations of our GAAP to non-GAAP measures.

(c)

Impact of the sale of the PPE business, the exit of the Company's private label diaper business in the United States, and
other exited businesses and markets in conjunction with the 2024 Transformation Initiative.

North America ("NA")

North America net sales of $2.7 billion decreased 1.9 percent in the quarter, driven by a combination of the PPE divestiture and the exit of the company's private label diaper business in the US, partially offset by organic sales growth. Organic sales increased 4.3 percent primarily driven by strong volume growth of 5.2 percentreflecting the strength of innovations and activations in the quarter. Personal Care categories grew weighted share by 60 basis points in the quarter. Year-to-date organic sales increased 1.8 percent with volume led growth at 2.6 percent partially offset by declines in price and mix.

Operating profit of $655 million decreased 4.0 percent driven primarily by a 500 basis point headwind from divestiture and business exits. Beyond that, results reflected volume led gains and strong productivity savings offset by planned investments in the price:value tiers of the portfolio and recent tariffs. Year-to-date operating profit was down 1.3 percent driven primarily by 390 basis point headwind from divestiture and business exits.

International Personal Care ("IPC")

IPC net sales of $1.4 billion increased 0.4 percent as organic sales growth of 3.3 percent, driven by strong volume led growth of 4.8 percent as we continually improve our value propositions across the portfolio, and improved portfolio mix 1.2percent,partially offset by unfavorable currency translation. Year-to-date organic sales were broadly in line with year ago.

Operating profit of $182 million decreased 12.9 percent driven by investments in price-value tiers resulting in negative pricing net of cost inflation partially offset by volume led gains and productivity savings. Year-to-date operating profit was down 16.7 percent.

Cash Flow and Balance Sheet

Year-to-date cash provided by operations (inclusive of discontinued operations) was $1.1 billion compared to $1.5 billionlast year driven mainly by the decline in operating profit. Year-to-date capital spending was $401million compared to $352million last year. The company returned $944 million to shareholders through dividends and repurchases of common stock. Total debt was $7.2 billion as of June 30, 2025, down from $7.4billion as of December 31, 2024.

2025 Outlook

The company adjusted its full-year outlook to be consistent with the reporting of the IFP business as discontinued operations. Its outlook for Net Sales, Organic Sales Growth and Adjusted Operating Profit growth now reflect the results of the remaining two segments, North America and IPC, as well as its overhead structure excluding the IFP business.Its outlook for Adjusted Earnings per Share Attributable to Kimberly-Clark and Adjusted Free Cash Flow will continue to include the IFP business until the close of the joint venture transaction with Suzano, anticipated to occur mid-year 2026.

Consistent with the Company's long term growth algorithm, 2025 Organic Sales Growth is expected to outpace the weighted average growth in the categories and countries it competes, which are currently growingat approximately two percent. Reported Net Sales are forecast to reflect a negative impact of approximately 100 basis points from currency translation, as well as a negative 290 basis point impact from a combination of the PPE divestiture and the exit of the company's private label diaper business in the US.

The company expects its 2025 Adjusted Operating Profit to grow at a low-to-mid single digit rate on a constant-currency basis versus the prior year. This outlook includes a negative 380 basis point impact from a combination of its PPE divestiture and the exit of the company's private label diaper business in the US. Operating Profit growth is also expected to be negatively impacted by approximately 100 basis points from currency translation.

Adjusted Earnings per Share Attributable to Kimberly-Clark are expected to grow at a low-to-mid single digit rate on a constant-currency basis including a negative 320 basis point impact from a combination of its PPE divestiture and the exit of the company's private label diaper business in the US, as well as a negative 100 basis point impact from items below operating profit including higher net interest expense, a higher effective adjusted tax rate, partially offset by lower shares outstanding. This outlook also includes a favorable impact of approximately 200 basis points, or $0.16 per diluted share, from the cessation of depreciation and amortization expense for assets held for sale, reflected in earnings from discontinued operations. Earnings Per Share are expected to be negatively impacted by approximately 150 basis points from currency translation, including the impact on income from equity interests.

Adjusted Free Cash Flow is expected to be approximately $2 billion in 2025.

This outlook reflects assumptions subject to change given the macro environment.

Supplemental Materials and Live Webcast

Supplemental materials will be available at approximately 6:35 a.m. Eastern Daylight Time in the Investor Relations section of the Kimberly-Clark website. The company will host a live Q&A session with investors and analysts on August 1, 2025, at 8:00 a.m. Eastern Daylight Time. The supplemental materials and Kimberly-Clark's Q&A session can be accessed at the Kimberly-Clark website. A replay of the webcast will be available following the event through the same website.

About Kimberly-Clark

Kimberly-Clark (NASDAQ: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries and territories. Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No. 1 or No. 2 share positions in approximately 70 countries. Our company's purpose is to deliver Better Care for a Better World. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come. To keep up with the latest news and learn more about the company's more than 150-year history of innovation, visit the .

Copies of Kimberly-Clark's Annual Report to Stockholders and its proxy statements and other SEC filings, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, are made available free of charge on the company's website on the same day they are filed with the SEC. To view these filings, visit the Investors section of the company's website.

Forward Looking Statements

Certain matters contained in this press release concerning the business outlook, including raw material, energy and other input costs, our plans and expectations regarding the pending IFP joint venture transaction with Suzano ("IFP Transaction"), the anticipated charges and savings from the 2024 Transformation Initiative, cash flow and uses of cash, growth initiatives, innovations, marketing and other spending, net sales, anticipated currency rates and exchange risks, including the impact in Argentina and Türkiye, effective tax rate, contingencies and anticipated transactions of Kimberly-Clark, including dividends, share repurchases and pension contributions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are based upon management's expectations and beliefs concerning future events impacting Kimberly-Clark. There can be no assurance that these future events will occur as anticipated or that our results will be as estimated. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to publicly update them.

The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on the achievement of future cost savings and projected volume increases. In addition, many factors outside our control, including risks and uncertainties around the pending IFP Transaction (including risks related to delays or failure to complete the proposed transaction, the incurrence of significant transaction and separation costs, adverse market reactions, regulatory or legal challenges, and operational disruptions), risks that we are not able to realize the anticipated benefits of the 2024 Transformation Initiative (including risks related to disruptions to our business or operations or related to any delays in implementation), war in Ukraine (including the related responses of consumers, customers, and suppliers and sanctions issued by the U.S., the European Union, Russia or other countries), government trade or similar regulatory actions (including current and potential trade and tariff actions affecting the countries where we operate and the resulting negative impacts on our supply chain, commodity costs, and consumer spending), pandemics, epidemics, fluctuations in foreign currency exchange rates, the prices and availability of our raw materials, supply chain disruptions, disruptions in the capital and credit markets, counterparty defaults (including customers, suppliers and financial institutions with which we do business), failure to realize the expected benefits or synergies from our acquisition and disposition activity, impairment of goodwill and intangible assets and our projections of operating results and other factors that may affect our impairment testing, changes in customer preferences, severe weather conditions, regional instabilities and hostilities (including the war in Israel), potential competitive pressures on selling prices for our products, energy costs, general economic and political conditions globally and in the markets in which we do business, as well as our ability to maintain key customer relationships, could affect the realization of these estimates.

The factors described under Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended December31, 2024, or in our other SEC filings, among others, could cause our future results to differ from those expressed in any forward-looking statements made by us or on our behalf. Other factors not presently known to us or that we presently consider immaterial could also affect our business operations and financial results.

KIMBERLY-CLARK CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Millions, except per share amounts)

(Unaudited)


Three Months Ended June 30




2025


2024


Change

Net Sales

$ 4,163


$ 4,231


(1.6%)

Cost of products sold

2,707


2,637


2.7%

Gross Profit

1,456


1,594


(8.7%)

Marketing, research and general expenses

863


967


(10.8%)

Other (income) and expense, net

1


88


(98.9%)

Operating Profit

592


539


9.8%

Nonoperating expense

(17)


(15)


13.3%

Interest income

5


9


(44.4%)

Interest expense

(67)


(72)


(6.9%)

Income from Continuing Operations Before Income Taxes and
Equity Interests

513


461


11.3%

Provision for income taxes

(116)


(60)


93.3%

Income from Continuing Operations Before Equity Interests

397


401


(1.0%)

Share of net income of equity companies

47


63


(25.4%)

Income from Continuing Operations

444


464


(4.3%)

Income from Discontinued Operations, Net of Income Taxes

68


89


(23.6%)

Net Income

512


553


(7.4%)

Net income attributable to noncontrolling interests

(3)


(9)


(66.7%)

Net Income Attributable to Kimberly-Clark Corporation

$ 509


$ 544


(6.4%)






Per Share Basis






Net Income Attributable to Kimberly-Clark Corporation






Basic:






Continuing operations

$ 1.33


$ 1.35


(1.5%)

Discontinued operations

0.20


0.26


(23.1%)

Basic Earnings per Share

$ 1.53


$ 1.61


(5.0%)






Diluted:






Continuing operations

$ 1.33


$ 1.35


(1.5%)

Discontinued operations

0.20


0.26


(23.1%)

Diluted Earnings per Share

$ 1.53


$ 1.61


(5.0%)







Cash Dividends Declared

$ 1.26


$ 1.22


3.3%












Common Shares Outstanding

June 30




2025


2024



Outstanding shares as of

331.9


337.0



Average diluted shares for three months ended

333.3


338.0



KIMBERLY-CLARK CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Millions, except per share amounts)

(Unaudited)


Six Months Ended June 30




2025


2024


Change

Net Sales

$ 8,217


$ 8,557


(4.0%)

Cost of products sold

5,252


5,277


(0.5%)

Gross Profit

2,965


3,280


(9.6%)

Marketing, research and general expenses

1,718


1,918


(10.4%)

Other (income) and expense, net

24


108


(77.8%)

Operating Profit

1,223


1,254


(2.5%)

Nonoperating expense

(34)


(30)


13.3%

Interest income

12


19


(36.8%)

Interest expense

(131)


(139)


(5.8%)

Income from Continuing Operations Before Income Taxes and
Equity Interests

1,070


1,104


(3.1%)

Provision for income taxes

(247)


(208)


18.8%

Income from Continuing Operations Before Equity Interests

823


896


(8.1%)

Share of net income of equity companies

91


124


(26.6%)

Income from Continuing Operations

914


1,020


(10.4%)

Income from Discontinued Operations, Net of Income Taxes

171


191


(10.5%)

Net Income

1,085


1,211


(10.4%)

Net income attributable to noncontrolling interests

(9)


(20)


(55.0%)

Net Income Attributable to Kimberly-Clark Corporation

$ 1,076


$ 1,191


(9.7%)






Per Share Basis






Net Income Attributable to Kimberly-Clark Corporation






Basic:






Continuing operations

$ 2.73


$ 2.97


(8.1%)

Discontinued operations

0.51


0.56


(8.9%)

Basic Earnings per Share

$ 3.24


$ 3.53


(8.2%)






Diluted:






Continuing operations

$ 2.72


$ 2.96


(8.1%)

Discontinued operations

0.51


0.56


(8.9%)

Diluted Earnings per Share

$ 3.23


$ 3.52


(8.2%)







Cash Dividends Declared

$ 2.52


$ 2.44


3.3%












Common Shares Outstanding

June 30




2025


2024



Average diluted shares for six months ended

333.3


338.2



KIMBERLY-CLARK CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Millions)

(Unaudited)



June 30, 2025


December 31, 2024

ASSETS





Current Assets





Cash and cash equivalents


$ 634


$ 1,010

Accounts receivable, net


2,007


1,728

Inventories


1,558


1,452

Other current assets


572


694

Current assets of discontinued operations


786


696

Total Current Assets


5,557


5,580

Property, Plant and Equipment, Net


6,317


6,284

Investments in Equity Companies


359


314

Goodwill


1,836


1,796

Other Intangible Assets, Net


81


80

Other Assets


1,001


984

Non-current Assets of Discontinued Operations


1,620


1,508

TOTAL ASSETS


$ 16,771


$ 16,546





LIABILITIES AND STOCKHOLDERS' EQUITY





Current Liabilities





Debt payable within one year


$ 771


$ 564

Trade accounts payable


3,253


3,264

Accrued expenses and other current liabilities


2,019


2,091

Dividends payable


415


402

Current liabilities of discontinued operations


713


683

Total Current Liabilities


7,171


7,004

Long-Term Debt


6,470


6,854

Non-current Employee Benefits


619


628

Deferred Income Taxes


243


300

Other Liabilities


680


609

Non-current Liabilities of Discontinued Operations


148


139

Redeemable Preferred Securities of Subsidiaries


37


37

Stockholders' Equity





Kimberly-Clark Corporation


1,271


840

Noncontrolling Interests


132


135

Total Stockholders' Equity


1,403


975

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY


$ 16,771


$ 16,546

KIMBERLY-CLARK CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Millions)

(Unaudited)



Six Months Ended June 30



2025


2024

Operating Activities





Net income


$ 1,085


$ 1,211

Depreciation and amortization


440


373

Asset impairments



5

Stock-based compensation


73


71

Deferred income taxes


(30)


(79)

Net (gains) losses on asset and business dispositions


36


83

Equity companies' earnings (in excess of) less than dividends paid


(50)


(82)

Operating working capital


(471)


(135)

Postretirement benefits


9


3

Other


5


9

Cash Provided by Operations


1,097


1,459

Investing Activities





Capital spending


(401)


(352)

Proceeds from asset and business dispositions


12


14

Investments in time deposits


(227)


(242)

Maturities of time deposits


282


235

Other


22


(31)

Cash Used for Investing


(312)


(376)

Financing Activities





Cash dividends paid


(824)


(809)

Change in short-term debt


51


7

Debt repayments


(250)


Proceeds from exercise of stock options


36


41

Repurchases of common stock


(120)


(156)

Cash dividends paid to noncontrolling interests


(18)


(19)

Other


(58)


(62)

Cash Used for Financing


(1,183)


(998)

Effect of Exchange Rate Changes on Cash and Cash Equivalents


34


(15)

Change in Cash and Cash Equivalents


(364)


70





Cash and cash equivalents from continuing operations - beginning of period


1,010


1,075

Cash and cash equivalents from discontinued operations - beginning of period (a)


11


18

Cash and Cash Equivalents - Beginning of Period


1,021


1,093





Cash and cash equivalents from continuing operations - end of period


634


1,149

Cash and cash equivalents from discontinued operations - end of period(a)


23


14

Cash and Cash Equivalents - End of Period


$ 657


$ 1,163

(a)

Included in Current assets of discontinued operations.

KIMBERLY-CLARK CORPORATION

BUSINESS SEGMENT RESULTS

(Millions)

(Unaudited)

‌�



Three Months Ended June 30




Six Months Ended
June 30





2025


2024


Change


2025


2024


Change

Net Sales













NA


$ 2,730


$ 2,783


(1.9%)


$ 5,398


$ 5,559


(2.9%)

IPC


1,433


1,427


0.4%


2,819


2,953


(4.5%)

Segment Net Sales(a)


4,163


4,210


(1.1%)


8,217


8,512


(3.5%)

Corporate & Other(b)



21


N.M.



45


N.M.

Total Net Sales


$ 4,163


$ 4,231


(1.6%)


$ 8,217


$ 8,557


(4.0%)













Operating Profit













NA


$ 655


$ 682


(4.0%)


$ 1,333


$ 1,351


(1.3%)

IPC


182


209


(12.9%)


383


460


(16.7%)

Segment Operating Profit(a)


837


891


(6.1%)


1,716


1,811


(5.2%)

Corporate & Other(b)


(245)


(352)


(30.4%)


(493)


(557)


(11.5%)

Total Operating Profit


$ 592


$ 539


9.8%


$ 1,223


$ 1,254


(2.5%)

(a)

Segment Net Sales and Segment Operating Profit are non-GAAP financial measures as they exclude certain results included
within Corporate & Other, as discussed below. Refer to "Summary of Non-GAAP Financial Measures" below for further discussion
of how we utilize non-GAAP financial measures. As shown above, we have included a reconciliation to Total Net Sales and Total
Operating Profit, as determined in accordance with GAAP.

(b)

Corporate & Other includes income and expense not associated with the ongoing operations of the segments, including certain
operations of the former IFP segment that were divested prior to the IFP Transaction and costs previously allocated to the former
IFP segment that aren't reported as discontinued operations.

N.M. - Not Meaningful

SUMMARY OF NON-GAAP FINANCIAL MEASURES
The following provides the reconciliation of the non-GAAP financial measures provided in this press release to the most closely related GAAP measure. These measures include: Organic Sales Growth, Adjusted Gross Profit, Adjusted Operating Profit, Adjusted Earnings per Share from Continuing Operations, Adjusted Earnings per Share Attributable to Kimberly-Clark, and Adjusted Effective Tax Rate. Unless specifically stated, all discussions regarding non-GAAP financial measures reflect results from our continuing operations for all periods presented.

  • Organic Sales Growth is defined as the change in Net Sales, as determined in accordance with U.S. GAAP, excluding the impacts of currency translation and divestitures and business exits.
  • Adjusted Gross and Operating Profit, Adjusted Earnings per Share from Continuing Operations, Adjusted Earnings per Share Attributable to Kimberly-Clark and Adjusted Effective Tax Rate are defined as Gross Profit, Operating Profit, Diluted Earnings per Share from Continuing Operations, Diluted Earnings per Share Attributable to Kimberly-Clark and Effective Tax Rate, respectively, as determined in accordance with U.S. GAAP, excluding the impacts of certain items that management believes do not reflect our underlying operations, and which are discussed in further detail below.

The income tax effect of these non-GAAP items on the Company's Adjusted Earnings per Share from Continuing Operations is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. The impact of these non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income from Continuing Operations Before Income Taxes and Equity Interests and Provision for income taxes.

We use these non-GAAP financial measures to assist in comparing our performance on a consistent basis for purposes of business decision making by removing the impact of certain items that we do not believe reflect our underlying and ongoing operations. We believe that presenting these non-GAAP financial measures is useful to investors because it (i) provides investors with meaningful supplemental information regarding financial performance by excluding certain items, (ii) permits investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating our results. We believe that the presentation of these non-GAAP financial measures, when considered together with the corresponding U.S. GAAP financial measures and the reconciliation to those measures, provides investors with additional understanding of the factors and trends affecting our business than could be obtained absent these disclosures.

These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with our Unaudited Interim Condensed Consolidated Financial Statements prepared in accordance with GAAP. There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded. We compensate for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures. Certain non-GAAP financial measures referenced in this press release are presented on a forward-looking basis. Kimberly-Clark does not provide a reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures on a forward-looking basis because it is unable to predict certain adjustment items without unreasonable effort. Please note that these items could be material to Kimberly-Clark's results calculated in accordance with GAAP.

The non-GAAP financial measures exclude the following items for the relevant time periods:

  • 2024 Transformation Initiative - We initiated this transformation to create a more agile and focused operating structure that will accelerate our proprietary pipeline of innovation in right-to-win spaces and improve our growth trajectory, profitability, and returns on investment.
  • IFP Repatriated Earnings � In connection with the IFP Transaction, we recognized a deferred tax liability for certain permanently reinvested earnings from the IFP Business that are expected to be repatriated prior to the close of the transaction.
  • IFP Separation Costs - Costs incurred in connection with the IFP Transaction related to external advisory, legal, accounting, contractor and other incremental costs.
  • IFP Tax Basis Adjustment - In connection with the IFP Transaction, we recognized a deferred tax liability on the difference between our book and tax basis for certain of our investments in subsidiaries reported as discontinued operations.

The following tables provide a reconciliation of Organic Sales Growth from continuing operations:



Three Months Ended June 30, 2025



Percent change vs. the prior year period



NA


IPC


Total

Net Sales Growth


(1.9)


0.4


(1.6)

Currency Translation


0.2


2.6


1.0

Divestitures and Business Exits


5.7


0.3


4.4

Organic Sales Growth(a)


4.3


3.3


3.9



Six Months Ended June 30, 2025



Percent change vs. the prior year period



NA


IPC


Total

Net Sales Growth


(2.9)


(4.5)


(4.0)

Currency Translation


0.3


4.3


1.7

Divestitures and Business Exits


4.3


0.3


3.4

Organic Sales Growth(a)


1.8


0.1


1.2

(a)

Table may not foot due to rounding.

The following table provides a reconciliation of Adjusted Gross Profit from continuing operations:



Three Months Ended June 30


Six Months Ended June 30



2025


2024


2025


2024

Gross Profit


$ 1,456


$ 1,594


$ 2,965


$ 3,280

2024 Transformation Initiative


82


45


135


45

Adjusted Gross Profit


$ 1,538


$ 1,639


$ 3,100


$ 3,325

The following table provides a reconciliation of Adjusted Operating Profit from continuing operations:



Three Months Ended June 30


Six Months Ended June 30



2025


2024


2025


2024

Operating Profit


$ 592


$ 539


$ 1,223


$ 1,254

2024 Transformation Initiative


121


190


196


235

Adjusted Operating Profit


$ 713


$ 729


$ 1,419


$ 1,489

The following table provides a reconciliation of Adjusted Earnings per Share from continuing operations:



Three Months Ended June 30


Six Months Ended June 30



2025


2024


2025


2024

Diluted Earnings per Share from Continuing Operations


$ 1.33


$ 1.35


$ 2.72


$ 2.96

2024 Transformation Initiative


0.27


0.35


0.50


0.45

IFP Repatriated Earnings


0.03



0.03


Adjusted Earnings per Share from Continuing Operations(a)


$ 1.63


$ 1.70


$ 3.25


$ 3.41

(a)

The non-GAAP adjustments included above are presented net of tax. The income tax effect of these non-GAAP items is calculated
based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
Refer to the Adjusted Effective Tax Rate reconciliation below for the tax effect of these adjustments on the Company's reported
Provision for income taxes.

The following table provides a reconciliation of Adjusted Earnings per Share Attributable to Kimberly-Clark:



Three Months Ended June 30


Six Months Ended June 30



2025


2024


2025


2024

Diluted Earnings per Share Attributable to Kimberly-Clark


$ 1.53


$ 1.61


$ 3.23


$ 3.52

2024 Transformation Initiative


0.27


0.35


0.50


0.45

IFP Separation Costs


0.07



0.07


IFP Repatriated Earnings


0.03



0.03


IFP Tax Basis Adjustment


0.02



0.02


Adjusted Earnings per Share Attributable to Kimberly-Clark


$ 1.92


$ 1.96


$ 3.85


$ 3.97

The following tables provide a reconciliation of the continuing operations Adjusted Effective Tax Rate:



Three Months Ended June 30



2025


2024



Income from
Continuing
Operations
Before Income
Taxes and
Equity
Interests


Provision for
Income Taxes


Income from
Continuing
Operations
Before Income
Taxes and
Equity
Interests


Provision for
Income Taxes

As Reported


$ 513


$ (116)


$ 461


$ (60)

2024 Transformation Initiative


122


(27)


190


(73)

IFP Repatriated Earnings



10



As Adjusted


$ 635


$ (133)


$ 651


$ (133)









Effective Tax Rate









As Reported




22.6%




13.0%

As Adjusted




20.9%




20.4%



Six Months Ended June 30



2025


2024



Income from
Continuing
Operations
Before Income
Taxes and
Equity
Interests


Provision for
Income Taxes


Income from
Continuing
Operations
Before Income
Taxes and
Equity
Interests


Provision for
Income Taxes

As Reported


$ 1,070


$ (247)


$ 1,104


$ (208)

2024 Transformation Initiative


199


(27)


235


(84)

IFP Repatriated Earnings



10



As Adjusted


$ 1,269


$ (264)


$ 1,339


$ (292)









Effective Tax Rate









As Reported




23.1%




18.8%

As Adjusted




20.8%




21.8%

[KMB-F]

Logo -

Cision View original content:

SOURCE Kimberly-Clark Corporation

FAQ

What were Kimberly-Clark's (KMB) key financial results for Q2 2025?

KMB reported Q2 2025 net sales of $4.2 billion (down 1.6%), organic sales growth of 3.9%, and adjusted EPS of $1.92 (down 2.0%). The company achieved volume growth of 5.0%, its highest in five years.

How did Kimberly-Clark's gross margin perform in Q2 2025?

KMB's adjusted gross margin was 36.9%, down 180 basis points versus the prior year, primarily due to unfavorable pricing net of cost inflation and incremental tariff-driven costs, partially offset by productivity gains.

What is Kimberly-Clark's outlook for 2025?

KMB expects low-to-mid single digit growth in adjusted operating profit and EPS on a constant-currency basis, with adjusted free cash flow projected at approximately $2 billion.

How did Kimberly-Clark's North America segment perform in Q2 2025?

North America net sales were $2.7 billion, with organic sales growth of 4.3% driven by strong volume growth of 5.2%. Personal Care categories grew weighted share by 60 basis points.

What was Kimberly-Clark's cash flow and capital allocation in 2025?

Year-to-date cash from operations was $1.1 billion, capital spending was $401 million, and KMB returned $944 million to shareholders through dividends and stock repurchases.
Kimberly-Clark Corp

NASDAQ:KMB

KMB Rankings

KMB Latest News

KMB Latest SEC Filings

KMB Stock Data

41.57B
331.05M
0.21%
81.45%
1.57%
Household & Personal Products
Converted Paper & Paperboard Prods (no Contaners/boxes)
United States
IRVING